Laboratory workforce shortages carry a substantial and measurable economic cost, not only a clinical one. Turnover-related costs alone amount to $4.82 million annually for the average hospital, covering recruiting, onboarding, and lost productivity. Hospitals turning to contract-based staffing to fill vacancies often pay two to three times the hourly rate of a full-time employee, and understaffed laboratories experience slower turnaround times that delay clinical decisions, extend hospital stays, and, in the United States, expose hospitals to Medicare readmission penalties of up to 3 percent of total reimbursement. The shortage is a financial problem for healthcare organizations as much as it is a staffing problem, and its costs compound the longer it goes unaddressed.
Laboratory testing informs the majority of medical decisions, and when the workforce that performs that testing is understaffed, the effects ripple far beyond the laboratory bench. Slower results delay treatment. Overworked staff burn out and leave, worsening the very shortage that caused their exhaustion. Hospitals pay premium rates for temporary staff to keep testing running. This article quantifies the economic impact of the laboratory workforce shortage, explains why the costs compound over time, and outlines what the data suggests about the return on investment in solving it.
The Direct Costs of Turnover and Vacancy
The most immediate economic impact of the laboratory workforce shortage shows up in the cost of turnover itself. Turnover-related costs, including recruiting expenses and new hire training, translate to a loss of $4.82 million annually for the average hospital, a figure that reflects the compounding expense of constantly replacing staff rather than retaining them. Underlying this loss is a troubling retention statistic: only 12 percent of laboratory technologists reported they were extremely likely to stay in the diagnostics field, meaning the pipeline of departures that drives these costs shows no sign of slowing on its own.
The reliance on contract and temporary staffing compounds the financial strain further. The cost of temporary workers brought in to fill vacancies is often two to three times higher than that of a full-time employee, and this premium comes with a further complication: exponentially higher hourly rates paired with compromised productivity and quality oversight, since temporary staff typically require more supervision and produce less throughput than experienced permanent employees, meaning hospitals pay more for less output.
Vacancy rates themselves have been documented at troubling levels for years. A 2018 survey found average vacancy rates of 7 to 11 percent in clinical laboratories, reaching as high as 25 percent in some areas, and workforce projections have consistently shown demand for laboratory technologists and technicians growing faster than the overall labor market. The Bureau of Labor Statistics has projected an 11 percent increase in laboratory technologist and technician positions, a growth rate that outpaces the supply of new graduates entering the field each year.
The Cascading Costs of Slower Turnaround
Beyond direct staffing costs, understaffed laboratories generate a second, less visible tier of economic damage through delayed testing turnaround.
Until a new technologist reaches full competency, laboratories often experience slower turnaround times and reduced throughput, creating downstream clinical delays and financial strain. These delays are not abstract. One real-world example documented average turnaround times exceeding national benchmarks by 30 to 40 percent, resulting in delays in clinical decision-making and increased emergency department pressure. In more severe cases, a 2025 investigative report uncovered critical microbiology results delayed by over 48 hours due to staff shortages, leading to multiple instances of misdiagnosis, delayed antibiotic therapy, and extended hospitalizations.
These clinical delays translate directly into financial penalties within the US reimbursement system. Unplanned readmissions within 30 days of discharge, under the Hospital Readmissions Reduction Program, can result in financial penalties of up to 3 percent of total Medicare reimbursement, and inefficient laboratory operations that delay or compromise results can directly contribute to these readmissions, particularly for conditions like heart failure, pneumonia, or infections where timely lab guidance is essential. A staffing shortage in the laboratory, in other words, does not stay contained to the laboratory’s budget line; it flows through into hospital-wide reimbursement penalties tied to the quality outcomes that timely, accurate testing makes possible.
Extended hospital stays represent a further hidden cost. Every day a patient’s discharge is delayed by a pending laboratory result or a diagnosis complicated by testing delays adds direct cost to the hospital and consumes capacity that could serve another patient, a form of economic loss that rarely appears explicitly in laboratory budget discussions but flows directly from laboratory staffing levels.
Why the Costs Compound Over Time
The economic impact of the laboratory workforce shortage is not static; it tends to worsen the longer it persists, through several reinforcing dynamics.
Burnout accelerates departures, which worsens the shortage that caused the burnout in the first place. As remaining staff absorb the workload of unfilled positions, job dissatisfaction driven by low wages, long hours, and intense pressure pushes more of them to leave, and each departure adds further burden to those who remain. This creates a self-reinforcing cycle in which the shortage generates the very conditions that deepen it.
The aging of the existing workforce adds a structural dimension to the cost trajectory. The laboratory workforce skews older than most healthcare professions, and as experienced professionals retire, they take with them institutional knowledge and troubleshooting expertise that cannot simply be replaced by hiring; it must be rebuilt over years, during which laboratories often run leaner and slower than they otherwise would.
Onboarding costs recur constantly rather than being one-time expenses, since high turnover means laboratories are perpetually training new staff rather than benefiting from a stable, experienced team. New hires must adapt not only to laboratory workflows but also to digital systems like laboratory information management systems and middleware, and this onboarding period further affects turnaround times and operational costs during a phase that, under high turnover, is never fully behind the organization.
What the Return on Investment Data Shows
Encouragingly, the same body of evidence that documents the cost of the shortage also demonstrates that investment in addressing it pays measurable returns.
One documented example examined a multi-hospital health system that invested in adding ten full-time equivalent laboratory technologists across its core facilities, providing a real-world basis for calculating return on investment, with the broader research literature indicating that hiring additional qualified technologists produces both measurable and impactful returns, offsetting their cost through faster turnaround, reduced reliance on expensive temporary staffing, and avoided readmission penalties.
Laboratories investing in automation alongside staffing report faster turnaround times, which in clinical settings translate to shorter patient stays with measurable financial impact, and improved retention, since removing tedious manual work from professionals’ days increases job satisfaction and decreases the turnover that drives replacement costs. This points toward a combined strategy, investing in both people and the technology that supports them, as the most cost-effective response rather than treating staffing and automation as competing priorities.
Legislative and workforce-development investment also shows promise as a longer-term economic lever. Initiatives such as the Medical Laboratory Personnel Shortage Relief Act provide grants to accredited institutions to train more clinical laboratory staff, representing a policy-level investment aimed at expanding the supply side of the workforce rather than only managing the symptoms of the shortage at the individual hospital level. Combined with community partnerships that connect training programs directly with employer needs, these structural investments offer the clearest path to reducing the shortage’s economic burden over the long term, rather than merely absorbing its costs indefinitely.
Conclusion
The laboratory workforce shortage is not merely an operational inconvenience; it is a quantifiable financial liability. Multi-million-dollar annual turnover costs, premium rates for temporary staffing, turnaround delays that trigger readmission penalties, and the self-reinforcing cycle of burnout and departure all combine to make the shortage one of the more significant, if under-recognized, economic pressures facing hospital laboratories today.
The evidence also points toward a clear response: investment in staffing, retention, automation, and workforce pipeline development pays measurable returns, both in avoided costs and in improved clinical performance. Treating the laboratory workforce shortage as a financial priority, not only a staffing concern, is essential for healthcare organizations seeking to protect both their margins and the quality of care their laboratories make possible.
Frequently Asked Questions
How much does the laboratory workforce shortage cost hospitals?
Turnover-related costs alone are estimated at $4.82 million annually for the average hospital, covering recruiting, onboarding, and lost productivity. Beyond turnover, hospitals pay two to three times the normal hourly rate for temporary contract staff to fill vacancies, and turnaround delays caused by understaffing can trigger Medicare readmission penalties of up to 3 percent of total reimbursement, adding further indirect costs.
Why is temporary or contract laboratory staffing so expensive?
Contract laboratory staff typically cost two to three times more per hour than full-time employees, and this premium comes without the productivity benefits of permanent, experienced staff. Temporary workers often require more supervision and produce lower throughput, meaning hospitals frequently pay significantly more for less output than a stable, well-trained permanent team would provide.
How does laboratory staffing affect hospital readmission penalties?
Understaffed laboratories often experience slower turnaround times, which can delay diagnosis and treatment for time-sensitive conditions like heart failure, pneumonia, or infections. These delays can contribute to unplanned readmissions within 30 days of discharge, which under the Hospital Readmissions Reduction Program can result in financial penalties of up to 3 percent of a hospital’s total Medicare reimbursement.
Does investing in more laboratory staff actually pay off financially?
Evidence suggests it does. Hospitals that have invested in additional laboratory technologists have documented measurable returns through faster turnaround times, reduced reliance on expensive temporary staffing, and fewer costly readmissions. Combining staffing investment with automation, which reduces manual burden and improves retention, appears to offer the strongest financial return.
What is being done to address the economic impact of the laboratory workforce shortage?
Responses include hospital investment in additional staffing and automation to improve retention and throughput, employer-education partnerships and apprenticeships that build a stronger training pipeline, and legislative measures such as grant funding for laboratory training programs. These strategies aim to address both the immediate costs of the shortage and its underlying structural causes.
Bio-Reach is a non-profit organization dedicated to advancing Laboratory Medicine through advocacy, education, and global collaboration. To learn more or get involved, visit bio-reach.org.
